-
1
-
-
0242300158
-
Heterogeneity of Toxicant Response: Sources of Human Variability
-
Aldridge JE, Gibbons JA, Flaherty MM, Kreider ML, Romano JA, et al. (2003) Heterogeneity of Toxicant Response: Sources of Human Variability. Toxicol Sci 76: 3-20.
-
(2003)
Toxicol Sci
, vol.76
, pp. 3-20
-
-
Aldridge, J.E.1
Gibbons, J.A.2
Flaherty, M.M.3
Kreider, M.L.4
Romano, J.A.5
-
2
-
-
79960856696
-
Targeting Translation Dependence in Cancer
-
Malina A, Cencic R, Pelletier J (2011) Targeting Translation Dependence in Cancer. Onco Target 2: 76-88.
-
(2011)
Onco Target
, vol.2
, pp. 76-88
-
-
Malina, A.1
Cencic, R.2
Pelletier, J.3
-
3
-
-
80053417028
-
Metformin inhibits melanoma development through autophagy and apoptosis mechanisms
-
Tomic T, Botton T, Cerezo M, Robert G, Luciano F, et al. (2011) Metformin inhibits melanoma development through autophagy and apoptosis mechanisms. Cell Death Dis 2: e199.
-
(2011)
Cell Death Dis
, vol.2
-
-
Tomic, T.1
Botton, T.2
Cerezo, M.3
Robert, G.4
Luciano, F.5
-
4
-
-
33845974091
-
Autophagy for cancer therapy through inhibition of pro-apoptotic proteins and mammalian target of rapamycin signaling
-
Kim KW, Mutter RW, Cao C, Albert JM, Freeman M, et al. (2006) Autophagy for cancer therapy through inhibition of pro-apoptotic proteins and mammalian target of rapamycin signaling. J Biol Chem 281: 36883-36890.
-
(2006)
J Biol Chem
, vol.281
, pp. 36883-36890
-
-
Kim, K.W.1
Mutter, R.W.2
Cao, C.3
Albert, J.M.4
Freeman, M.5
-
5
-
-
36348950449
-
Metformin Inhibits Mammalian Target of Rapamycin-Dependent Translation Initiation in Breast Cancer Cells
-
Dowling RJ, Zakikhani M, Fantus G, Pollak M, Sonenberg N (2007) Metformin Inhibits Mammalian Target of Rapamycin-Dependent Translation Initiation in Breast Cancer Cells. Cancer Res 67: 10804-10812.
-
(2007)
Cancer Res
, vol.67
, pp. 10804-10812
-
-
Dowling, R.J.1
Zakikhani, M.2
Fantus, G.3
Pollak, M.4
Sonenberg, N.5
-
6
-
-
63149173251
-
Standards of medical care in diabetes-2009
-
American Diabetes Association
-
American Diabetes Association (2009) Standards of medical care in diabetes-2009. Diabetes Care 1: S13-61.
-
(2009)
Diabetes Care
, vol.1
-
-
-
7
-
-
67650945180
-
Antidiabetic therapies affect risk of pancreatic cancer
-
Li D, Yeung SC, Hassan MM, Konopleva M, Abbruzzese JL (2009) Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology 137: 482-488.
-
(2009)
Gastroenterology
, vol.137
, pp. 482-488
-
-
Li, D.1
Yeung, S.C.2
Hassan, M.M.3
Konopleva, M.4
Abbruzzese, J.L.5
-
10
-
-
84862064131
-
Statin Use as a Moderator of Metformin Effect on Risk for Prostate Cancer Among Type 2 Diabetic Patients
-
Lehman DM, Lorenzo C, Hernandez J, Wang CP (2012) Statin Use as a Moderator of Metformin Effect on Risk for Prostate Cancer Among Type 2 Diabetic Patients. Diabetes Care 35: 1002-1007.
-
(2012)
Diabetes Care
, vol.35
, pp. 1002-1007
-
-
Lehman, D.M.1
Lorenzo, C.2
Hernandez, J.3
Wang, C.P.4
-
11
-
-
36348950449
-
Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells
-
Dowling RJ, Zakikhani M, Fantus IG, Pollak M, Sonenberg N (2007) Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells. Cancer Res 67: 10804-10812.
-
(2007)
Cancer Res
, vol.67
, pp. 10804-10812
-
-
Dowling, R.J.1
Zakikhani, M.2
Fantus, I.G.3
Pollak, M.4
Sonenberg, N.5
-
12
-
-
33751284806
-
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
-
Zakikhani M, Dowling R, Fantus IG, Sonenberg N, Pollak M (2006) Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res 66: 10269-10273.
-
(2006)
Cancer Res
, vol.66
, pp. 10269-10273
-
-
Zakikhani, M.1
Dowling, R.2
Fantus, I.G.3
Sonenberg, N.4
Pollak, M.5
-
13
-
-
44849099894
-
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
-
Ben Sahra I, Laurent K, Loubat A, Giorgetti-Peraldi S, Colosetti P, et al. (2008) The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level. Oncogene 27: 3576-3586.
-
(2008)
Oncogene
, vol.27
, pp. 3576-3586
-
-
Ben Sahra, I.1
Laurent, K.2
Loubat, A.3
Giorgetti-Peraldi, S.4
Colosetti, P.5
-
14
-
-
34848834225
-
Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer
-
Mulligan AM, O'Malley FP, Ennis M, Fantus IG, Goodwin PJ (2007) Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer. Breast Cancer Res Treat 106: 39-47.
-
(2007)
Breast Cancer Res Treat
, vol.106
, pp. 39-47
-
-
Mulligan, A.M.1
O'Malley, F.P.2
Ennis, M.3
Fantus, I.G.4
Goodwin, P.J.5
-
15
-
-
33845803595
-
Oral Antidiabetic Drugs: Effect of Food on Absorption of Pioglitazone and Metformin From a Fixed-Dose Combination Tablet
-
Karim A, Slater M, Bradford D, Schwartz L, Laurent A (2007) Oral Antidiabetic Drugs: Effect of Food on Absorption of Pioglitazone and Metformin From a Fixed-Dose Combination Tablet. J Clin Pharmacol 47: 48-55.
-
(2007)
J Clin Pharmacol
, vol.47
, pp. 48-55
-
-
Karim, A.1
Slater, M.2
Bradford, D.3
Schwartz, L.4
Laurent, A.5
-
16
-
-
34249069215
-
Dual antiglioma action of metformin: Cell cycle arrest and mitochondriadependent apoptosis
-
Isakovic A, Harhaji L, Stevanovic D, Markovic Z, Sumarac-Dumanovic M, et al. (2007) Dual antiglioma action of metformin: cell cycle arrest and mitochondriadependent apoptosis. Cell Mol Life Sci 64: 1290-1302.
-
(2007)
Cell Mol Life Sci
, vol.64
, pp. 1290-1302
-
-
Isakovic, A.1
Harhaji, L.2
Stevanovic, D.3
Markovic, Z.4
Sumarac-Dumanovic, M.5
-
17
-
-
0019941487
-
Biological diversity in metastatic neoplasms: Origins and implications
-
Fidler IJ, Hart IR (1982) Biological diversity in metastatic neoplasms: origins and implications. Science 217: 998-1003.
-
(1982)
Science
, vol.217
, pp. 998-1003
-
-
Fidler, I.J.1
Hart, I.R.2
-
18
-
-
43149106499
-
The diabetes drug metformin is emerging as a potential treatment for breast cancer on the basis of evidence that cancer patients with lower insulin levels have better outcomes
-
Hede K (2008) The diabetes drug metformin is emerging as a potential treatment for breast cancer on the basis of evidence that cancer patients with lower insulin levels have better outcomes. JNCI 100: 530-532.
-
(2008)
JNCI
, vol.100
, pp. 530-532
-
-
Hede, K.1
-
20
-
-
20444461067
-
Metformin and reduced risk of cancer in diabetic patients
-
Evans JM, Donnelly LA, Emslie-Smith AM, Alessi DR, Morris AD (2005) Metformin and reduced risk of cancer in diabetic patients. BMJ 330: 1304-1305.
-
(2005)
BMJ
, vol.330
, pp. 1304-1305
-
-
Evans, J.M.1
Donnelly, L.A.2
Emslie-Smith, A.M.3
Alessi, D.R.4
Morris, A.D.5
-
21
-
-
79953661884
-
Understanding the benefit of metformin use in cancer treatment
-
Dowling JC, Goodwin PJ, Stambolic V (2011) Understanding the benefit of metformin use in cancer treatment. BMC Med 9: 33.
-
(2011)
BMC Med
, vol.9
, pp. 33
-
-
Dowling, J.C.1
Goodwin, P.J.2
Stambolic, V.3
-
22
-
-
0036022593
-
Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3
-
Hayer-Zillgen M, Brüss M, Bönisch H (2002) Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3. Br J Pharmacol 136: 829-836.
-
(2002)
Br J Pharmacol
, vol.136
, pp. 829-836
-
-
Hayer-Zillgen, M.1
Brüss, M.2
Bönisch, H.3
-
23
-
-
0034900493
-
Glucose Transporter Glut-1 Expression Correlates with Tumor Hypoxia and Predicts Metastasis-free Survival in Advanced Carcinoma of the Cervix1
-
Airley R, Loncaster J, Davidson S, Bromley M, Roberts S, et al. (2001) Glucose Transporter Glut-1 Expression Correlates with Tumor Hypoxia and Predicts Metastasis-free Survival in Advanced Carcinoma of the Cervix1. Clin Cancer Res 7: 928-934.
-
(2001)
Clin Cancer Res
, vol.7
, pp. 928-934
-
-
Airley, R.1
Loncaster, J.2
Davidson, S.3
Bromley, M.4
Roberts, S.5
-
24
-
-
79959207505
-
Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth
-
Rocha GZ, Dias MM, Ropelle ER, Osório-Costa F, Rossato FA, et al. (2011) Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth. Clin Cancer Res 17: 3993-4005.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 3993-4005
-
-
Rocha, G.Z.1
Dias, M.M.2
Ropelle, E.R.3
Osório-Costa, F.4
Rossato, F.A.5
-
25
-
-
33751284806
-
Metformin Is an AMP Kinase-Dependent Growth Inhibitor for Breast Cancer Cells
-
Zakikhani M, Dowling R, Fantus IG, Sonenberg N, Pollak M (2006) Metformin Is an AMP Kinase-Dependent Growth Inhibitor for Breast Cancer Cells. Cancer Res 66: 10269-10273.
-
(2006)
Cancer Res
, vol.66
, pp. 10269-10273
-
-
Zakikhani, M.1
Dowling, R.2
Fantus, I.G.3
Sonenberg, N.4
Pollak, M.5
-
26
-
-
70350236538
-
Metformin Selectively Targets Cancer StemCells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
-
Hirsch HA, Illopoulos D, TsichlisPN, Struhl K (2009) Metformin Selectively Targets Cancer StemCells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission. Cancer Res 69: 7507-7511.
-
(2009)
Cancer Res
, vol.69
, pp. 7507-7511
-
-
Hirsch, H.A.1
Illopoulos, D.2
Tsichlis, P.N.3
Struhl, K.4
-
27
-
-
77957005003
-
Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status
-
Vazquez-Martin A, Oliveras-Ferraros C, Cufi S, Del Barco S, Martin-Castillo B, et al. (2010) Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status. Cell Cycle 9:18, 3807-3814.
-
(2010)
Cell Cycle
, vol.9
-
-
Vazquez-Martin, A.1
Oliveras-Ferraros, C.2
Cufi, S.3
Del Barco, S.4
Martin-Castillo, B.5
-
28
-
-
67650514082
-
Metformin induces unique biological and molecular responses in triple negative breast cancer cells
-
Liu B, Fan Z, Edgerton SM, Deng XS, Alimova IN, et al. (2009) Metformin induces unique biological and molecular responses in triple negative breast cancer cells. Cell Cycle 8: 2031-2040.
-
(2009)
Cell Cycle
, vol.8
, pp. 2031-2040
-
-
Liu, B.1
Fan, Z.2
Edgerton, S.M.3
Deng, X.S.4
Alimova, I.N.5
-
29
-
-
0031945458
-
Cell cycle regulation and apoptosis
-
King KL, Cidlowski JA (1998) Cell cycle regulation and apoptosis. Annu Rev Physiol 60: 601-617.
-
(1998)
Annu Rev Physiol
, vol.60
, pp. 601-617
-
-
King, K.L.1
Cidlowski, J.A.2
|